ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,646,063 | +5.8% | 318,514 | +19.7% | 0.03% | +7.7% |
| Q2 2023 | $8,173,873 | +59.3% | 265,990 | +86.8% | 0.03% | +23.8% |
| Q1 2023 | $5,131,537 | +1.8% | 142,424 | +11.6% | 0.02% | -8.7% |
| Q4 2022 | $5,041,668 | +4.5% | 127,621 | +6.3% | 0.02% | -4.2% |
| Q3 2022 | $4,823,000 | -7.5% | 120,009 | -3.2% | 0.02% | 0.0% |
| Q2 2022 | $5,216,000 | +8.0% | 123,988 | 0.0% | 0.02% | +26.3% |
| Q1 2022 | $4,830,000 | +2.6% | 123,988 | +5.0% | 0.02% | +5.6% |
| Q4 2021 | $4,707,000 | +10.3% | 118,084 | 0.0% | 0.02% | +5.9% |
| Q3 2021 | $4,266,000 | -11.9% | 118,084 | 0.0% | 0.02% | -15.0% |
| Q2 2021 | $4,841,000 | -6.0% | 118,084 | 0.0% | 0.02% | -16.7% |
| Q1 2021 | $5,151,000 | – | 118,084 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |